作者: Jitender Sareen , Alla Kirshner , Mark Lander , Kevin D. Kjernisted , Michael K. Eleff
DOI: 10.1016/J.JAD.2004.03.011
关键词: Psychology 、 Serotonin reuptake inhibitor 、 Anxiety disorder 、 Psychiatry 、 Antipsychotic 、 Olanzapine 、 Atypical antipsychotic 、 Risperidone 、 Antidepressant 、 Quetiapine
摘要: Abstract Background: Paradoxically, some reports in the literature support use of antipsychotics treatment Obsessive Compulsive Disorder (OCD), while other suggest that can exacerbate OCD symptoms. To date, there is no published systematic review relationship between symptoms and antipsychotic drugs. Methods: A Medline PsychInfo search (1980–2003) was conducted to collect interactions Results: In refractory OCD, case series, open label trials placebo-controlled were found suggesting efficacy augmentation ongoing antidepressant treatment. with haloperidol, risperidone, olanzapine, quetiapine, a significantly higher response rate (46–71%) for groups, compared placebo groups. Reports exacerbation atypical limited individuals primary psychotic disorder. Limitations: Definition most these studies based on modest reduction symptoms, available long-term efficacy. There also systematically evaluated incidence associated antipsychotics. Conclusions: All mentioned above had short-term controlled evidence their as augmenting agents OCD. The suggested management induction/exacerbation due increase dose and/or add selective serotonin reuptake inhibitor.